View in EDS HTML Full Text PDF Full Text

Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection.

Saved in:
Bibliographic Details
Title: Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection.
Authors: He, Taiyu1 (AUTHOR), Zhou, Yingzhi1 (AUTHOR), Xu, Pan1 (AUTHOR), Ling, Ning1 (AUTHOR), Chen, Min1 (AUTHOR), Huang, Tianquan1 (AUTHOR), Zhang, Biqiong1 (AUTHOR), Yang, Ziqiao1 (AUTHOR), Ao, Ling1 (AUTHOR), Li, Hu1 (AUTHOR), Chen, Zhiwei1 (AUTHOR), Zhang, Dazhi1 (AUTHOR), Shi, Xiaofeng1 (AUTHOR), Lei, Yu1 (AUTHOR), Wang, Zhiyi1 (AUTHOR), Zeng, Weiqun1 (AUTHOR), Hu, Peng1 (AUTHOR), Lan, Yinghua1 (AUTHOR), Zhou, Zhi1 (AUTHOR), Kang, Juan1 (AUTHOR)
Source: Liver International. Jun2022, Vol. 42 Issue 6, p1287-1296. 10p. 3 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14783223
DOI:10.1111/liv.15173